Skip to main content
. 2021 Jan 11;11:431. doi: 10.1038/s41598-020-80164-w

Table 1.

Basic donor parameters.

Control Early-Onset AD Late-Onset AD
Sex 12 M/14 F 7 M/9 F 8 M/10 F
Age (years)
 M 70.7 ± 9.85 63.1 ± 5.61 82.9 ± 5.38*
 F 70.8 ± 14.8 54.2 ± 7.16* 83.4 ± 6.35
PMI (hours)
 M 16.7 ± 8.50 25.2 ± 10.6 22.7 ± 8.54
 F 21.7 ± 12.7 18.5 ± 9.87 20.4 ± 7.98
Brain weight (grams)
 M 1275 ± 155.1 1157 ± 139.2 1126 ± 98.9*
 F 1191 ± 108.6 879.4 ± 143.4*** 992.0 ± 94.9*

The brain samples analyzed for soluble Aβ peptides were obtained from neurologically normal cases (Control) and from histopathologically confirmed cases of Early-Onset or Late-Onset Alzheimer disease (AD). M, male; F, female; years (time-at-death; age at autopsy); PMI, post-mortem interval; *P < 0.05; ***P < 0.001; vs. control donors (mean ± sem).